from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2288/-

LFCtreatmentdescriptionclass of inhibitor

0.635

Amikacinug/mL Amikacintranslation

0.477

Cap5-10ug/mL Capreomycintranslation

0.806

Rox10-50 ug/mL Roxithromycintranslation

-0.345

SM2-5 ug/mL Streptomycintranslation

0.419

Tet5-10 ug/mL Tetracyclinetranslation

-0.371

Rif0.2-5ug/mL Rifampicintranscription

0.506

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.040

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.226

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.059

CPZ10-50 ug/mL Chlorpromazinerespiration

0.026

Clofazimine10-13 ug/mL Clofaziminerespiration

0.196

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.152

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.511

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.386

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.553

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.324

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.998

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.508

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.217

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.070

KCN5-20 ug/mL Potassium cyaniderespiration

0.877

NaN30.2-2 mM Sodium aziderespiration

-0.095

Nigericin50 uM Nigericinrespiration

0.241

TRC10-150 ug/mL Triclosanrespiration

-0.942

TRZ10-25 ug/mL Thioridazinerespiration

-1.110

Valinomycin0.5-10 uM Valinomycinrespiration

0.530

ZnSO42 mM ZnSO4respiration

-0.339

menadione6-10 ug/mL Menadionerespiration

0.679

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.634

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.581

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.062

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.745

NRP_1Non-replicating persistence stage 1dosRassociated

-0.500

Amp0.2mg/mL AmpicillincellWall

0.312

Cephalexin20-100 ug/mL CephalexincellWall

-0.299

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.871

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.875

EMB10-20 ug/mL EthambutolcellWall

-0.506

Eta12-40 ug/mL EthionamidecellWall

-0.311

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.145

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.207

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.249

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.160

BZA0.12 mg/mL BenzamidearomaticAmides

0.353

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.302

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.218

H2O24 mM hydrogen peroxideDNAdamaging

0.599

Levo10 ug/mL LevofloxacinDNAdamaging

0.698

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.546

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.205

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.342

UVUV-irradiationDNAdamaging

0.004

ARP41-4 ug/mL Antitubercular compound ARP4?

0.646

Antimycin12.5-50 ug/mL Antimycin A?

-0.393

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.557

PA_110-50 ug/mL Antitubercular compound PA-1?

0.777

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.029

PA8240.2-2 ug/mL PA-824?

-0.759

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.235

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.003

Verapamil50 uM Verapamil?

-0.668

mercaptoethanol2 mM 2-Mercaptoethanol?

0.346

methoxatin10-20 ug/mL Methoxatin?